1. Chemotherapy-induced ovarian failure in young women with early breast cancer: Prospective analysis of four randomised neoadjuvant/adjuvant breast cancer trials. (July 2021) Authors: Furlanetto, Jenny; Marmé, Frederik; Seiler, Sabine; Thode, Christian; Untch, Michael; Schmatloch, Sabine; Schneeweiss, Andreas; Bassy, Martina; Fasching, Peter A.; Strik, Dominika; Stickeler, Elmar; Schem, Christian; Karn, Thomas; Grischke, Eva-Maria; Denkert, Carsten; van Mackelenbergh, Marion; ... Journal: European journal of cancer Issue: Volume 152(2021) Page Start: 193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials. Issue 8 (August 2021) Authors: Denkert, Carsten; Seither, Fenja; Schneeweiss, Andreas; Link, Theresa; Blohmer, Jens-Uwe; Just, Marianne; Wimberger, Pauline; Forberger, Almuth; Tesch, Hans; Jackisch, Christian; Schmatloch, Sabine; Reinisch, Mattea; Solomayer, Erich F; Schmitt, Wolfgang D; Hanusch, Claus; Fasching, Peter A; Lübb... Journal: Lancet oncology Issue: Volume 22:Issue 8(2021) Page Start: 1151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Endocrine Therapy in Premenopausal Hormone Receptor Positive/Human Epidermal Growth Receptor 2 Negative Metastatic Breast Cancer: Between Guidelines and Literature. (22nd June 2018) Authors: Tancredi, Richard; Furlanetto, Jenny; Loibl, Sibylle Journal: Oncologist Issue: Volume 23:Number 8(2018) Page Start: 974 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy. (March 2021) Authors: Furlanetto, Jenny; Möbus, Volker; Schneeweiss, Andreas; Rhiem, Kerstin; Tesch, Hans; Blohmer, Jens-Uwe; Lübbe, Kristina; Untch, Michael; Salat, Christoph; Huober, Jens; Klare, Peter; Schmutzler, Rita; Couch, Fergus J.; Lederer, Bianca; Gerber, Bernd; Zahm, Dirk-Michael; Bauerfeind, Ingo; Nekljudo... Journal: European journal of cancer Issue: Volume 145(2021) Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Integrating CDK4/6 inhibitors in the treatment of patients with early breast cancer. (March 2022) Authors: Loibl, Sibylle; Furlanetto, Jenny Journal: Breast Issue: Volume 62(2022)Supplement 1 Page Start: S70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phase III randomised trial comparing intense dose-dense chemotherapy to tailored dose-dense chemotherapy in high-risk early breast cancer (GAIN-2). (October 2021) Authors: Möbus, Volker; Lück, Hans-Joachim; Ladda, Ekkehart; Klare, Peter; Schmidt, Marcus; Schneeweiss, Andreas; Grischke, Eva-Maria; Wachsmann, Grischa; Forstbauer, Helmut; Untch, Michael; Marmé, Frederik; Blohmer, Jens-Uwe; Jackisch, Christian; Huober, Jens; Stickeler, Elmar; Reinisch, Mattea; Link, Th... Journal: European journal of cancer Issue: Volume 156(2021) Page Start: 138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. Issue 1 (January 2018) Authors: Denkert, Carsten; von Minckwitz, Gunter; Darb-Esfahani, Silvia; Lederer, Bianca; Heppner, Barbara I; Weber, Karsten E; Budczies, Jan; Huober, Jens; Klauschen, Frederick; Furlanetto, Jenny; Schmitt, Wolfgang D; Blohmer, Jens-Uwe; Karn, Thomas; Pfitzner, Berit M; Kümmel, Sherko; Engels, Knut; Schne... Journal: Lancet oncology Issue: Volume 19:Issue 1(2018) Page Start: 40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗